Less Ads, More Data, More Tools Register for FREE

Pin to quick picksMarks & Spencer Regulatory News (MKS)

Share Price Information for Marks & Spencer (MKS)

Share Price is delayed by 15 minutes
Get Live Data
358.40    -6.70 (-1.84%)
Bid:
355.30
Ask:
355.70
Spread: 0.40 (0.113%)
Market Cap: £7.36b
MKS Live PriceLast checked at - London Stock Exchange

Intraday Marks & Spencer Share Chart

Director/PDMR Shareholding

24 Jun 2014 14:29

RNS Number : 4163K
Marks & Spencer Group PLC
24 June 2014
 



Marks and Spencer Group Plc (the 'Company') Notification of Transactions Of Directors/Persons Discharging Managerial Responsibility

 

1. Performance Share PlanIt was confirmed on 24 June 2014 that on 23 June 2014 the following awards under the Marks and Spencer Group Performance Share Plan were made to PDMRs of the Company:

Directors

Allocation of Performance Shares

(See Note Below)

Marc Bolland

557,780

Patrick Bosquet-Chavanne 1

300,343

John Dixon

343,249

Steve Rowe

300,343

Alan Stewart

331,235

Laura Wade-Gery

315,789

 

Note: This award was granted as a nil cost option, where a participant will normally be entitled to exercise their award and receive free shares between the third and tenth anniversary of grant, subject to the extent to which performance conditions have been satisfied and their continuing employment 1. The vesting of the award will depend on the Company's earnings per share (EPS), return on capital (ROCE) and Revenue performance over a fixed three-year performance period starting on the first day of the financial year in which the award was granted. The value of dividends accrued, in the form of dividend equivalents, will be paid at the end of period (third anniversary) based on the number of vested Shares. No consideration was paid for the grant of the award. No price is payable on the exercise of the award. For the purposes of this award, the grant was made at a Share price of £4.37

1 Patrick Bosquet-Chavanne award is structured as conditional shares which vest on the third anniversary of grant.

 

3. Shareholdings of PDMRs

Directors

Total Holding of Ordinary Shares

Total Percentage Holding in the Company

Marc Bolland

498,111

De minimis

Patrick Bosquet-Chavanne

2,000

De minimis

John Dixon

276,399

De minimis

Steve Rowe

261,724

De minimis

Alan Stewart

51,622

De minimis

Laura Wade-Gery

118,324

De minimis

The above holdings are at 24 June 2014, being the date of this announcement, and include holdings for Connected Persons.

The above information has been disclosed under DTR 3.1.4

 

For Queries please contact:

Corporate PR +44 (0)20 8718 1919

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
RDSXZLFLZQFLBBV
Date   Source Headline
29th Jul 202512:43 pmRNSDirector/PDMR Shareholding
18th Jul 20252:57 pmRNSDirector/PDMR Shareholding
9th Jul 20259:59 amRNSDirector/PDMR Shareholding
7th Jul 20251:43 pmRNSDirector/PDMR Shareholding
1st Jul 20251:47 pmRNSResult of AGM
1st Jul 20259:00 amRNSBlock listing Interim Review
1st Jul 20259:00 amRNSTotal Voting Rights
30th Jun 20251:23 pmRNSDirector/PDMR Shareholding
23rd Jun 20252:38 pmRNSDirector/PDMR Shareholding
6th Jun 20252:07 pmRNSDirector/PDMR Shareholding
2nd Jun 202510:00 amRNSAnnual Financial Report
2nd Jun 20259:00 amRNSTotal Voting Rights
28th May 20254:53 pmRNSDirector/PDMR Shareholding
21st May 20257:00 amRNSFinal Results
13th May 20258:30 amRNSCyber Incident - Further Update
1st May 20259:00 amRNSTotal Voting Rights
29th Apr 202512:55 pmRNSDirector/PDMR Shareholding
25th Apr 20251:43 pmRNSCyber Incident - Further Update
22nd Apr 20252:14 pmRNSCyber Incident Update
1st Apr 20259:00 amRNSTotal Voting Rights
28th Mar 202512:42 pmRNSDirector/PDMR Shareholding
25th Mar 202512:07 pmRNSDirector/PDMR Shareholding
3rd Mar 20259:00 amRNSTotal Voting Rights
28th Feb 202511:20 amRNSDirector/PDMR Shareholding
3rd Feb 20259:00 amRNSTotal Voting Rights
28th Jan 20251:51 pmRNSDirector/PDMR Shareholding
13th Jan 20254:43 pmRNSDirector/PDMR Shareholding
9th Jan 20257:00 amRNSChristmas Trading Results
2nd Jan 20259:00 amRNSTotal Voting Rights
2nd Jan 20259:00 amRNSBlock listing Interim Review
30th Dec 202411:04 amRNSDirector/PDMR Shareholding
6th Dec 202411:09 amRNSDirector/PDMR Shareholding
2nd Dec 20249:00 amRNSTotal Voting Rights
28th Nov 202410:58 amRNSDirector/PDMR Shareholding
26th Nov 20243:43 pmRNSHolding(s) in Company
12th Nov 20249:08 amRNSInvestor Presentation
6th Nov 20247:00 amRNSHalf-year Report
1st Nov 20249:00 amRNSTotal Voting Rights
29th Oct 20243:32 pmRNSDirector/PDMR Shareholding
1st Oct 20249:00 amRNSTotal Voting Rights
30th Sep 202412:35 pmRNSDirector/PDMR Shareholding
26th Sep 202410:05 amRNSDirectorate Change
18th Sep 202411:53 amRNSDirector/PDMR Shareholding
2nd Sep 20249:00 amRNSTotal Voting Rights
30th Aug 202410:37 amRNSDirector/PDMR Shareholding
29th Aug 20249:00 amRNSDirector/PDMR Shareholding
20th Aug 202411:05 amRNSDirector/PDMR Shareholding
8th Aug 202411:30 amRNSConfirmation of CFO appointment date
1st Aug 20249:00 amRNSTotal Voting Rights
31st Jul 20249:00 amRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.